Multiplexed detection of biological agents

• US 20050250146A1
• Filed: 05/06/2005
• Published: 11/10/2005
• Est. Priority Date: 05/07/2004
• Status: Active Grant

• Current Assignee: Cepheid (Danaher Corporation)
• Original Assignee: Cepheid (Danaher Corporation)
• Inventors: McMillan, William A.
• Granted Patent: US 7,294,466 B2
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6816 characterised by the detection means C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 2537/143 Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
• CPC Class Codes: C12Q 2563/107 fluorescence
• CPC Class Codes: C12Q 2565/102 Multiple non-interacting labels
• CPC Class Codes: G01N 33/68 involving proteins, peptides or amino acids involving lipoproteins G01N33/92

Abstract

Described are methods, kits and systems for multiplexed detection of biological agents in a sample, e.g., multiplexed detection of e.g., bacteria, viruses, and biological toxins. The method utilizes two markers for each agent; the presence or absence in a sample of each of the two markers per agent is determined in separate reactions; however each reaction is used to detect a single marker for multiple agents. Also disclosed is the multiplexed detection method using real time PCR. The invention provides an efficient, cost-effective, and specific method for multiplexed detection of biological agents.

Claims

1. A method for detecting at least first and second biological agents, the first agent comprising first and second markers, and the second agent comprising third and fourth markers, the method comprising:

(a) preparing first and second mixtures from at least one sample suspected of containing the agents;

(b) detecting the presence or absence of the first and third markers in the first mixture in a first container; and

(c) detecting the presence or absence of the second and fourth markers in the second mixture in a second container;

whereby the presence of the first and second markers indicates the presence of the first biological agent in the sample, and the presence of the third and fourth markers indicates the presence of the second biological agent in the sample.

2. The method of claim 1, wherein the first, second, third and fourth markers are selected from the group consisting of nucleic acids, proteins and polysaccharides.

3. The method of claim 1, wherein:

the first mixture comprises a first probe specifically recognizing the first marker and a third probe specifically recognizing the third marker;

the second mixture comprises a second probe specifically recognizing the second marker and a fourth probe specifically recognizing the fourth marker;

detecting step (b) comprises determining the presence or absence of the first and the third probe binding to the first and the third markers in the first mixture; and

detecting step (c) comprises determining the presence or absence of the second and the fourth probe binding to the second and the fourth markers in the second mixture.

4. The method of claim 3, wherein the first, second, third or fourth probe is selected from the group consisting of nucleic acids and antibodies.

5. The method of claim 3, wherein each of the probes has a detectable label, the detectable label of the first probe is the same as the detectable label of the second probe, and the detectable label of the third probe is different from the detective label of the fourth probe.

6. The method of claim 3, wherein each of the probes has a fluorescent label, the fluorescent label of the first and second probes have respective emission maxima wavelengths within 100 nm of each other, and the fluorescent labels of the third and fourth probes have respective emission maxima wavelengths that differ by more than 100 nm.

7. The method of claim 4, wherein at least the first probe is a nucleic acid probe, and at least the fourth probe is an antibody.

8. The method of claim 7, wherein detecting the presence or absence of the first marker comprises PCR amplifying the first marker and hybridizing the first probe to the amplified marker.

9. The method of claim 7, wherein detecting the presence or absence of the fourth marker comprises immunospecifically binding the fourth probe to the fourth marker.

10. The method of claim 3, wherein the probes and the markers are nucleic acids and detecting the presence or absence of the markers in the mixtures is performed using PCR.

11. The method of claim 1, wherein the first and second mixtures are prepared from the same sample.

12. The method of claim 1, wherein the first, second, third, and fourth markers comprise first, second, third, and fourth nucleic acid sequences, the first mixture contains hybridization probes for labeling the first and third nucleic acid sequences, and the second mixture contains hybridization probes for labeling the second and fourth nucleic acid sequences.

13. The method of claim 1, wherein at least 3 biological agents are detected in the sample.

14. The method of claim 1, wherein at least 4 biological agents are detected in a sample.

15. A method for optically detecting the presence or absence of a number of biological agents greater than the number of color channels used to detect the presence or absence of the biological agents, each of the biological agents having respective first and second nucleic acid sequences that differentiate the biological agent from the other biological agents, the method comprising the steps of:

a) forming first and second mixtures in first and second containers, respectively, from at least one sample suspected of containing the biological agents, wherein;

i) the first mixture contains, for each of the biological agents, a respective first probe set for labeling the first nucleic acid sequence of the biological agent;

ii) the second mixture contains, for each of the biological agents, a respective second probe set for labeling the second nucleic acid sequence of the biological agent;

iii) at least two of the first probe sets in the first mixture have the same emission wavelength ranges to be detected in the same color channel, and the at least two corresponding second probe sets in the second mixture have different emission wavelength ranges to be detected in different color channels;

b) optically reading the presence or absence of probe signals from the at least two of the first probe sets in the first mixture have the same emission wavelength ranges;

c) optically reading the presence or absence of probe signals from the at least two corresponding second probe sets in the second mixture have different emission wavelength ranges; and

d) determining from the combination of probe signals received from each of the mixtures the presence or absence of the biological agents.

16. A method for detecting at least first and second biological agents, the first agent comprising first and second markers, and the second agent comprising third and fourth markers, the method comprising:

a) preparing a first mixture in a first container from at least one sample suspected of containing the agents;

b) detecting the presence or absence of the first and third markers in the first container;

c) if either of the first or third markers is present in the first container, preparing a second mixture in a second container from the at least one sample; and

d) detecting the presence or absence of the second and fourth markers in the second container;

whereby the presence of the first and second markers indicates the presence of the first biological agent in the sample, and the presence of the third and fourth markers indicates the presence of the second biological agent in the sample.

17. The method of claim 16, wherein the first, second, third, and fourth markers comprise first, second, third, and fourth nucleic acid sequences, the first mixture contains reagents and probes for amplifying and detecting the first and the third nucleic acid sequences, and the step of detecting the presence or absence of the first and third markers in the first container comprises subjecting the first mixture to nucleic acid amplification conditions and determining from probe signals if either of the first or third nucleic acid sequences is present in the first mixture.

18. The method of claim 17, wherein the second mixture contains reagents and probes for amplifying and detecting the second and the fourth nucleic acid sequences, and the step of detecting the presence or absence of the second and fourth markers in the second container comprises subjecting the second mixture to nucleic acid amplification conditions and determining from probe signals if either of the second or fourth nucleic acid sequences is present in the second mixture.

19. A kit for detecting at least first and second biological agents, the first agent comprising first and second markers, and the second agent comprising third and fourth markers, the kit comprising at least first and second containers, wherein the first container houses a first probe specifically recognizing the first marker and a second probe specifically recognizing the third marker, and wherein the second container houses a third probe specifically recognizing the second marker and a fourth probe specifically recognizing the fourth marker.

20. The kit of claim 19, wherein the first, second, third and fourth markers are selected from the group consisting of nucleic acids, proteins and polysaccharides.

21. The kit of claim 19, wherein the first, second, third or fourth probe is selected from the group consisting of nucleic acids and antibodies.

22. The kit of claim 19, wherein each of the probes has a detectable label, the detectable label of the first probe is the same as the detectable label of the third probe, and the detectable label of the second probe is different from the detective label of the fourth probe.

23. The kit of claim 19, wherein each of the probes has a fluorescent label, and wherein the fluorescent label of the first and second probes have respective absorbance maxima wavelengths within 100 nm of each other.

24. The kit of claim 19, wherein each of the probes has a fluorescent label, the fluorescent labels of the first and second probes have respective emission maxima wavelengths within 100 nm of each other, and the third and fourth probes have respective emission maxima wavelengths that differ by more than 100 nm.

25. The kit of claim 19, wherein at least the first probe is a nucleic acid probe, and at least the fourth probe is an antibody.

26. The kit of claim 19, wherein the first, second, third, and fourth markers comprise first, second, third, and fourth nucleic acid sequences, respectively, and wherein the probes comprise hybridization probes for labeling the nucleic acid sequences.

27. The kit of claim 26, wherein the first container further contains primers for amplifying the first and third nucleic acid sequences, and wherein the second container further contains primers for amplifying the second and fourth nucleic acid sequences.

28. The kit of claim 19, wherein the first, second, third, and fourth markers comprise first, second, third, and fourth nucleic acid sequences, respectively, the first container further contains amplification reagents for amplifying the first and third nucleic acid sequences, and wherein the second container further contains amplification reagents for amplifying the second and fourth nucleic acid sequences.

29. A system for detecting at least first and second biological agents, wherein the first agent comprises first and second markers, and the second agent comprises third and fourth markers, the system comprising:

(a) at least first and second containers, the first container housing reagents for detecting the first and third markers and the second container housing reagents for detecting the second and fourth markers;

(b) at least one detector arranged to detect the presence or absence of the markers in the containers; and

(c) at least one controller in communication with the at least one detector, the controller being programmed with computer-readable instructions to perform a series of operations comprising;

i) initiating a detection reaction in the first container;

ii) receiving data from the detector; and

iii) determining from the data the presence or absence of the first and third markers in the first container;

wherein if the first or third markers is present in the first container, the controller performs a second series of operations comprising;

iv) initiating a second detection reaction in the second container;

v) receiving additional data from the detector; and

vi) determining from the additional data the presence or absence of the second or fourth markers in the second container;

whereby the presence of the first and second markers indicates the presence of the first biological agent in a sample, and the presence of the third and fourth markers indicates the presence of the second biological agent in the sample.

30. The system of claim 29, wherein the markers are nucleic acids, the reagents housed in the first container are nucleic acid probes specifically recognizing the first and the third markers, and the reagents housed in the second container are nucleic acid probes specifically recognizing the second and the fourth markers.

31. The system of claim 30, wherein the detection reaction comprises nucleic acid amplification.

32. The system of claim 29, wherein the system comprises at least first and second detectors in communication with the controller, the first detector being arranged to detect the presence or absence of one or more of the markers in the first container, and the second detector being arranged to detect the presence or absence of one or more of the markers in the second container.

33. The system of claim 29, wherein the first, second, third, and fourth markers comprise first, second, third, and fourth nucleic acid sequences, and wherein the first and second containers comprise cartridges for extracting nucleic acid from a sample and for holding the nucleic acid for detection.

34. An automated system for determining the presence or absence of a plurality of agents, each of the agents comprising respective first and second nucleic acid sequences that differentiate the agent from the other agents, the automated system comprising:

a) at least one temperature control system for subjecting first and second reaction mixtures suspected of containing the agents to nucleic acid amplification conditions, the first reaction mixture containing reagents and probes for amplifying and detecting the first nucleic acid sequence of each of the agents, and the second reaction mixture containing reagents and probes for amplifying and detecting the second nucleic acid sequence of each of the agents;

b) at least one detection mechanism arranged to detect probe signals from the reaction mixtures; and

c) at least one controller in communication with the at least one temperature control system and with the at least one detection mechanism, the controller being programmed to perform the steps of;

i) sending control signals to the temperature control system to subject the first reaction mixture to nucleic acid amplification conditions;

ii) determining from probe signals received from the first reaction mixture if the first nucleic acid sequence of any of the agents is present in the first reaction mixture;

iii) if the first nucleic acid sequence of any of the agents is present in the first reaction mixture, then sending control signals to the temperature control system to subject the second reaction mixture to nucleic acid amplification conditions; and

iv) determining from probe signals received from the second reaction mixture if the second nucleic acid sequence of any of the agents is present in the second reaction mixture;

whereby the presence of the first and the second nucleic acid sequences of any of the agents is indicative of the presence of that agent.

35. The system of claim 34, wherein the system comprises at least first and second detection mechanisms in communication with the controller, the first detection mechanism being arranged to detect the presence or absence of one or more of the nucleic acid sequences in the first reaction mixture, and the second detection mechanism being arranged to detect the presence or absence of one or more of the nucleic acid sequences in the second reaction mixture.